NovaBridge Biosciences NBP Q4 2025 Earnings Staggering EPS Miss as PreRevenue Biotech Faces Development Headwinds Workday Q1 2026 Earnings EPS Beat Drives Solid Stock Rally UTHR Q1 2026 Earnings EPS Misses Estimates as Operational Costs Weigh on Results Eledon Pharmaceuticals Q1 2026 Earnings EPS Misses Estimates as Company Continues Clinical Pipeline Development DocuSign Q1 2026 Earnings EPS Beat Drives Slight Stock Gain NXST Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Performance